Showing results (21-30 of 672) with videos related to
Sort By:
Pageof 68
Future Microbiology|May 17, 2018
Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineeringMatteo Bassetti, Elda Righi, Davide Pecori, et al.Current Opinion in Infectious Diseases|January 4, 2018
The role of dalbavancin in skin and soft tissue infectionsMatteo Bassetti, Maddalena Peghin, Alessia Carnelutti, et al.The Journal of Antimicrobial Chemotherapy|January 6, 2018
What has changed in the treatment of invasive candidiasis? A look at the past 10 years and aheadMatteo Bassetti, Elda Righi, Philippe Montravers, et al.Future Microbiology|December 17, 2008
Drug treatment for multidrug-resistant Acinetobacter baumannii infectionsMatteo Bassetti, Elda Righi, Silvano Esposito, et al.Current Medicinal Chemistry|February 10, 2009
Current status of newer carbapenemsMatteo Bassetti, Laura Nicolini, Silvano Esposito, et al.Expert Opinion on Investigational Drugs|April 2, 2009
The role of telavancin in the treatment of MRSA infections in hospitalMatteo Bassetti, Malgorzata Mikulska, Elda Righi, et al.Current Opinion in Infectious Diseases|January 17, 2018
New antibiotics for ventilator-associated pneumoniaMatteo Bassetti, Antionio Vena, Nadia Castaldo, et al.World Journal of Gastroenterology|October 20, 2015
Impact of new treatment options for hepatitis C virus infection in liver transplantationElda Righi, Angela Londero, Alessia Carnelutti, et al.Expert Opinion on Drug Metabolism & Toxicology|October 10, 2017
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infectionsMatteo Bassetti, Davide Pecori, Piergiorgio Cojutti, et al.Drugs in Context|June 7, 2018
How to manage <i>Pseudomonas aeruginosa</i> infectionsMatteo Bassetti, Antonio Vena, Antony Croxatto, et al.Pageof 68